Skip to main content
padlock icon - secure page this page is secure

Differential Characteristics of HMGB2 Versus HMGB1 and their Perspectives in Ovary and Prostate Cancer

Buy Article:

Price: $68.00 + tax (Refund Policy)

We have summarized common and differential functions of HMGB1 and HMGB2 proteins with reference to pathological processes, with a special focus on cancer. Currently, several “omic” approaches help us compare the relative expression of these 2 proteins in healthy and cancerous human specimens, as well as in a wide range of cancer-derived cell lines, or in fetal versus adult cells. Molecules that interfere with HMGB1 functions, though through different mechanisms, have been extensively tested as therapeutic agents in animal models in recent years, and their effects are summarized. The review concludes with a discussion on the perspectives of HMGB molecules as targets in prostate and ovarian cancers.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: HMGB proteins; Prostate cancer; differential expression; drug targets; ovarian cancer

Affiliations: 1: EXPRELA Group, Centro de Investigacións Científicas Avanzadas (CICA), Departamento de Bioloxía. Facultade de Ciencias, INIBIC- Universidade da Coruña, Campus de A Coruña, 15071, A Coruña, Spain. 2: Translational Cancer Research Group, Instituto de Investigación Biomédica de A Coruña (INIBIC), Carretera del Pasaje s/n, 15006 A Coruña, Spain.

Appeared or available online: July 17, 2019

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more